Neuroprotection by antioxidants in models of global and focal ischemia.
Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285.
J A
JA
Clemens
J A
JA
Panetta
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology; D002545:Brain Ischemia / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D002839:Chromans / Q000494:pharmacology; D003342:Corpus Striatum / Q000187:drug effects* / Q000473:pathology; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology; D002546:Ischemic Attack, Transient / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000473:pathology / Q000517:prevention & control; D013329:Structure-Activity Relationship
D000975:Antioxidants; D002839:Chromans; D001205:Ascorbic Acid; C010643:6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid